BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8751763)

  • 1. Intrahepatic arterial chemoembolization for hepatocellular carcinoma and metastatic neuroendocrine tumors in the era of liver transplantation.
    Martin M; Tarara D; Wu YM; Ukah F; Fabrega A; Corwin C; Lang E; Mitros F
    Am Surg; 1996 Sep; 62(9):724-32. PubMed ID: 8751763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
    Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
    Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma.
    Harnois DM; Steers J; Andrews JC; Rubin JC; Pitot HC; Burgart L; Wiesner RH; Gores GJ
    Liver Transpl Surg; 1999 May; 5(3):192-9. PubMed ID: 10226109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
    Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W
    Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current treatment of hepatocellular carcinoma. Analysis of a series of 123 cases over a 5-year period].
    Popescu I; Ionescu M; Ciurea S; Braşoveanu V; Sârbu-Boeţi P; Hrehoreţ D; Tomulescu V; Alexandrescu S; Dorobanţu B; Grigorie R; Jemna C; Gheorghe L; Anghel R; Croitoru A; Herlea V; Boroş M
    Chirurgia (Bucur); 2005; 100(4):321-31. PubMed ID: 16238194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
    Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP
    Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma.
    Otto G; Heise M; Moench C; Herber S; Bittinger F; Schuchmann M; Hoppe-Lotichius M; Pitton M
    Transplant Proc; 2007 Mar; 39(2):537-9. PubMed ID: 17362776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences in liver transplantation for hepatocellular carcinoma.
    Stadlbauer V; Schaffellner S; Kniepeiss D; Jakoby E; Stauber R; Iberer F; Tscheliessnigg KH
    Transplant Proc; 2004; 36(1):195-8. PubMed ID: 15013344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization is a safe treatment for unresectable hepatic malignancies.
    Lopez RR; Pan SH; Lois JF; McMonigle ME; Hoffman AL; Sher LS; Lugo D; Makowka L
    Am Surg; 1997 Oct; 63(10):923-6. PubMed ID: 9322674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality management of hepatocellular carcinoma larger than 10 cm.
    Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
    J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Three cases of hepatocellular carcinoma, over 3 cm in diameter, with liver cirrhosis treated with combination of radiofrequency ablation and continuous hepatic arterial infusion chemotherapy].
    Hirashita T; Nakashima K; Sakai M; Sakai I
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1123-6. PubMed ID: 17637554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.
    Moreno Planas JM; López Monclús J; Gómez Cruz A; Rubio González E; Pérez Arangüena R; Boullosa Graña E; Garcia Suárez A; Pérez-Picouto JL; Fernández Ruiz M; Lucena de la Poza JL; Sánchez Turrión V; Cuervas-Mons Martínez V
    Transplant Proc; 2005 Apr; 37(3):1484-5. PubMed ID: 15866648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
    Wen J; Shen WL; Yang SH
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of resection and transplantation for hepatocellular carcinoma in cirrhosis and noncirrhosis.
    Rayya F; Harms J; Bartels M; Uhlmann D; Hauss J; Fangmann J
    Transplant Proc; 2008 May; 40(4):933-5. PubMed ID: 18555082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions.
    Wakabayashi H; Ushiyama T; Ishimura K; Izuishi K; Karasawa Y; Masaki T; Watanabe S; Kuriyama S; Maeta H
    J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.